Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?-Reference-Cited by-同舟云学术

Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?

Published:2020-05-14 Issue:9 Volume:75 Page:2704-2706
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Baldelli Sara¹,Corbellino Mario²,Clementi Emilio³⁴,Cattaneo Dario¹⁵,Gervasoni Cristina²⁵

Affiliation:

1. Unit of Clinical Pharmacology, Fatebenefratelli Sacco University Hospital, Milan, Italy

2. 3rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

3. Unit of Clinical Pharmacology, Fatebenefratelli Sacco University Hospital, Department of Biomedical and Clinical Sciences L. Sacco, Università di Milano, Milan, Italy

4. IRCCS E, Nedea Scientific Institute, Bosisio Parini, Italy

5. Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/75/9/2704/33665028/dkaa190.pdf

Reference13 articles.

1. A trial of lopinavir/ritonavir in adults hospitalized with severe Covid-19;Cao;N Engl J Med,2020

2. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19);Bartiromo;Transpl Infect Dis,2020

3. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore;Young;JAMA,2020

4. Liver injury during highly pathogenic human coronavirus infections;Xu;Liver Int,2020

5. Liver injury in COVID-19: management and challenges;Zhang;Lancet Gastroenterol Hepatol,2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Case of Dolutegravir Plus Darunavir Antiretroviral Regimens: Is It Always Useful to Double the Drug Doses? A Short Communication;Therapeutic Drug Monitoring;2024-09-05

2. Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19;Microorganisms;2024-08-16

3. Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial;International Journal of Infectious Diseases;2023-03

4. Coupling the Within-Host Process and Between-Host Transmission of COVID-19 Suggests Vaccination and School Closures are Critical;Bulletin of Mathematical Biology;2022-12-19

5. Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment;Current Pharmaceutical Design;2022-12